{
  "retracted": false,
  "timestamp": 1551398400000,
  "updates": [
    {
      "timestamp": 1574872046499,
      "identifier": {
        "doi": "10.1016/j.critrevonc.2019.01.007"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.critrevonc.2018.06.003"
  },
  "journal": "Critical Reviews in Oncology/Hematology",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Incidence and clinical parameters associated with eribulin mesylate-induced peripheral neuropathy” [Crit. Rev. Oncol./Hematol. 128 (August) (2018) 110–117]"
}
